| scholarly article | Q13442814 |
| P2093 | author name string | David A Schwartz | |
| Susan K Mathai | |||
| Laura A Warg | |||
| P2860 | cites work | WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis | Q24650922 |
| Telomerase and idiopathic pulmonary fibrosis | Q26825080 | ||
| Epigenomics of idiopathic pulmonary fibrosis | Q26853673 | ||
| A mutation in the surfactant protein C gene associated with familial interstitial lung disease | Q28201394 | ||
| Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis | Q28247967 | ||
| Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy | Q28268639 | ||
| Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis | Q28283421 | ||
| Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis | Q28291143 | ||
| A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia | Q28307444 | ||
| An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management | Q28308246 | ||
| Muc5b is required for airway defence | Q28589969 | ||
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis | Q28943334 | ||
| Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study | Q28943525 | ||
| A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis | Q29417118 | ||
| Telomerase mutations in families with idiopathic pulmonary fibrosis | Q29615671 | ||
| Pulmonary complications of radiation therapy | Q33200874 | ||
| Functional Wnt signaling is increased in idiopathic pulmonary fibrosis | Q33334369 | ||
| Ancestral mutation in telomerase causes defects in repeat addition processivity and manifests as familial pulmonary fibrosis. | Q33869660 | ||
| Genome-wide association identifies OBFC1 as a locus involved in human leukocyte telomere biology | Q33927045 | ||
| Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model | Q33955628 | ||
| Association between variations in cell cycle genes and idiopathic pulmonary fibrosis | Q34146071 | ||
| Mutant surfactant A2 proteins associated with familial pulmonary fibrosis and lung cancer induce TGF-β1 secretion | Q34316498 | ||
| The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium | Q34634190 | ||
| Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis | Q34737461 | ||
| DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway | Q34758600 | ||
| The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population | Q34935466 | ||
| A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis | Q35083039 | ||
| A promoter SNP rs4073T>A in the common allele of the interleukin 8 gene is associated with the development of idiopathic pulmonary fibrosis via the IL-8 protein enhancing mode | Q35121363 | ||
| Interstitial lung disease and pulmonary fibrosis in Hermansky-Pudlak syndrome type 2, an adaptor protein-3 complex disease | Q35718958 | ||
| Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis | Q35749152 | ||
| Adult-onset pulmonary fibrosis caused by mutations in telomerase | Q35759839 | ||
| Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells | Q35771616 | ||
| A common MUC5B promoter polymorphism and pulmonary fibrosis. | Q36048530 | ||
| Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention | Q36166696 | ||
| Clinical and pathologic features of familial interstitial pneumonia | Q36234581 | ||
| A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features | Q36295215 | ||
| The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis | Q36447402 | ||
| Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis | Q36485998 | ||
| Is idiopathic pulmonary fibrosis an environmental disease? | Q36493941 | ||
| Short telomeres are a risk factor for idiopathic pulmonary fibrosis | Q36861819 | ||
| Telomere shortening in familial and sporadic pulmonary fibrosis | Q36915503 | ||
| MUC5B promoter polymorphism and interstitial lung abnormalities | Q37105760 | ||
| Telomerase and telomere length in pulmonary fibrosis. | Q37297921 | ||
| Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease | Q37388520 | ||
| Exposures and idiopathic lung disease | Q37394734 | ||
| Genes involved in innate immunity associated with asbestos-related fibrotic changes | Q37465454 | ||
| Genome wide association and linkage analyses identified three loci-4q25, 17q23.2, and 10q11.21-associated with variation in leukocyte telomere length: the Long Life Family Study. | Q37489298 | ||
| Identification of seven loci affecting mean telomere length and their association with disease | Q37735420 | ||
| Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema | Q38119789 | ||
| Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63. | Q38361937 | ||
| hTERT mutations associated with idiopathic pulmonary fibrosis affect telomerase activity, telomere length, and cell growth by distinct mechanisms | Q39390523 | ||
| Promoter analysis and aberrant expression of the MUC5B gene in diffuse panbronchiolitis | Q40446157 | ||
| A FAMILY STUDY OF IDIOPATHIC PULMONARY FIBROSIS. A POSSIBLE DYSPROTEINEMIC AND GENETICALLY DETERMINED DISEASE. | Q40964891 | ||
| Increased pulmonary toxicity with bleomycin and cisplatin chemotherapy combinations | Q46976556 | ||
| Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study. | Q50900397 | ||
| Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. | Q51041008 | ||
| Heterogeneous distribution of mechanical stress in human lung: a mathematical approach to evaluate abnormal remodeling in IPF. | Q51219439 | ||
| Asbestos and the lung in the 21st century: an update. | Q51428846 | ||
| Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. | Q53758579 | ||
| The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. | Q54241841 | ||
| Occupational and Environmental Risk Factors for Idiopathic Pulmonary Fibrosis: A Multicenter Case-Control Study | Q58002571 | ||
| Familial chronic interstitial pneumonia | Q67249998 | ||
| Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members | Q69497791 | ||
| Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition | Q70653157 | ||
| Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity | Q73062445 | ||
| Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis | Q77487068 | ||
| Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms | Q85394442 | ||
| Is telomeropathy the explanation for combined pulmonary fibrosis and emphysema syndrome?: report of a family with TERT mutation | Q87440569 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pulmonary fibrosis | Q32446 |
| P304 | page(s) | 429-35 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Current Opinion in Pulmonary Medicine | Q23930051 |
| P1476 | title | Genetic susceptibility and pulmonary fibrosis | |
| P478 | volume | 20 |
| Q91996723 | Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF) |
| Q36119163 | Epigenetics in lung fibrosis: from pathobiology to treatment perspective |
| Q38560347 | Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases |
| Q38543042 | Facts and promises on lung biomarkers in interstitial lung diseases |
| Q42367959 | Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment |
| Q38821078 | Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways |
| Q35786160 | Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis |
| Q59125554 | Laminin α1 is a genetic modifier of TGF-β1-stimulated pulmonary fibrosis |
| Q36490141 | MUC5B and Idiopathic Pulmonary Fibrosis |
| Q29248145 | Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis |
| Q38995612 | Pulmonary fibrosis in the era of stratified medicine. |
| Q91622811 | Translational research in pulmonary fibrosis |
Search more.